Download ![]() |
< Back |
28 Oct 2022 | |
RUBRA MEDICAMENTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2022 ,inter alia, to consider and approve Standalone Unaudited Financial Results along with limited review report, Asset and liability statement and Cash Flow Statement of the Company for the half year ended September 30, 2022. | |
View all announcements for RUBRA MEDICAMENTS LTD. | Source: BSE India |